397 Shares in Intuitive Surgical, Inc. $ISRG Purchased by Gradient Capital Advisors LLC

Gradient Capital Advisors LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 397 shares of the medical equipment provider’s stock, valued at approximately $216,000.

Other large investors have also bought and sold shares of the company. Norway Savings Bank raised its holdings in Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after buying an additional 910 shares during the last quarter. IronOak Wealth LLC. purchased a new position in Intuitive Surgical in the second quarter worth about $1,099,000. Trust Co. of Oklahoma purchased a new position in Intuitive Surgical in the second quarter worth about $363,000. Neville Rodie & Shaw Inc. raised its holdings in Intuitive Surgical by 11.9% in the second quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after buying an additional 1,110 shares during the last quarter. Finally, Compagnie Lombard Odier SCmA raised its holdings in Intuitive Surgical by 633.9% in the second quarter. Compagnie Lombard Odier SCmA now owns 33,311 shares of the medical equipment provider’s stock worth $18,102,000 after buying an additional 28,772 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 0.7%

ISRG opened at $441.12 on Friday. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The stock has a market capitalization of $158.13 billion, a price-to-earnings ratio of 61.52, a PEG ratio of 4.59 and a beta of 1.61. The firm has a 50 day moving average price of $469.43 and a 200-day moving average price of $501.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same period in the prior year, the company earned $1.78 earnings per share. The firm’s revenue was up 21.4% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have issued reports on ISRG shares. Truist Financial lifted their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday. UBS Group boosted their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. Evercore ISI boosted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $595.95.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.